Investments in health systems


What are Investments in health systems at AstraZeneca?

Company contributions to strengthening healthcare capabilities and infrastructure — including in developing and emerging markets — to facilitate access to healthcare and improved quality of healthcare and outcomes.   


Our approach

The nature of diseases and infection and their risk factors call for multi-sector involvement in prevention and control measures. We work with stakeholders to align on our shared objectives and develop interventions that are optimised to address local challenges, while leveraging our experience in health programming. 

We aim to build the capabilities of healthcare systems to best respond to patient needs by:

  • Remaining culturally relevant and ensuring programming is locally appropriate 
  • Using our global footprint to scale partnerships 
  • Establishing mechanisms for collaboration with our partners, for example through joint coordination, planning, follow up and agreement of a set of core indicators for monitoring and evaluation

In 2020, we launched The Partnership for Health System Sustainability and Resilience (PHSSR) with the London School of Economics (LSE) and the World Economic Forum (WEF), motivated by a shared commitment to improving population health, through and beyond the COVID-19 pandemic. Change is needed to build health systems that are both resilient to crises and sustainable in the face of long-term stresses. From new models of care, to innovative financing mechanisms and breakthrough technologies, PHSSR aims to make change happen, by identifying transferable solutions with the greatest potential, and supporting their adoption to deliver better health and better care for all. Read more about our approach to health systems resilience here.


Our key targets and progress


See the Sustainability Data Summary for all metrics and methodology.


Our stories

Investments aligned with our business capabilities
We have three main therapy areas — oncology; cardiovascular, renal and metabolism; and respiratory. Our investments in health systems are aligned to these therapy areas, to ensure connection to our overall company strategy and business model. The stories below outline 2020 progress for each therapy area.


Oncology:

Investing to transform cancer care
Early cancer screening programme in India
Phakamisa oncology programme renewed

Cardiovascular, renal and metabolism:

Healthy Heart Africa pivots to address COVID-19
Donation of 10,000 blood pressure monitors
Project Heartbeat in India

Respiratory:

Redefining care for severe asthma patients across the globe
Africa Pumua Initiative

Learn more about Investments in health systems in our Sustainability Report.